AMSF
AMERISAFE, Inc.
AMSF's fundamentals are mixed, but it looks cheap: trading at 9.0x earnings, below its usual 15x. Analysts expect earnings to decline.
IREN
IREN Limited
There isn't enough reported data to score IREN yet.
AMSF Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| N/A | |
| N/A |
AMSF's revenue and profitability are currently stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like AMSF.
IREN Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| N/A | |
| N/A |
IREN's revenue and profitability are currently under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like IREN.
AMSF PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 9x | $19.32 | — |
| Forward | 10x | $19.32 | — |
| Cheap | 12x | $26.07 | +35% |
| Fair | 15x | $31.51 | +63% |
| Expensive | 18x | $38.29 | +98% |
Historical ranges are pointers, not guarantees.
AMSF's PE is in its cheap range at 9.0x. Analysts expect earnings to fall, which would put today's price at 10x next year's earnings.
IREN PE Valuation
IREN has no meaningful PE right now: it lost money over the past year.
AMSF Forward outlook
| Metric | Outlook |
|---|---|
| Deteriorating | |
| Decline | |
| Stable | |
| Strongly weakening | |
| Limited | |
| High |
Analysts expect AMSF's earnings and profitability to decline, with its revenue holding steady.
IREN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
IREN has the edge over AMSF on the outlook, with more favorable revenue and profitability expectations.
AMSF Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.87 | -13% |
| Q3 2026 | $2.15 | -18% |
| Q2 2026 | $2.48 | -6.1% |
| Q1 2026 | $2.43 | -2% |
| Q4 2025 | $2.47 | -15% |
| Q3 2025 | $2.61 | -18% |
| Q2 2025 | $2.64 | -11% |
| Q1 2025 | $2.48 | -23% |
| Q4 2024 | $2.89 | -11% |
AMSF has the edge over IREN on earnings quality, reporting a profit while its opponent remains loss making.
IREN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$3.96 | -347% |
| Q2 2026 | -$2.22 | -988% |
| Q1 2026 | $0.51 | +$1.10 |
| Q4 2025 | $1.18 | +$1.62 |
| Q3 2025 | $1.60 | +$1.99 |
| Q2 2025 | $0.25 | +$0.45 |
| Q1 2025 | -$0.59 | -$0.43 |
| Q4 2024 | -$0.44 | -$0.15 |
IREN has swung to a loss: it lost $3.96 per share over the past year, after a profit the year before.
AMSF Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $79.8M | -2.6% |
| Q2 2026 | $92M | +13% |
| Q1 2026 | $80.1M | +10% |
| Q4 2025 | $81.6M | +10% |
| Q3 2025 | $82M | +4.2% |
| Q2 2025 | $81.1M | +6.9% |
| Q1 2025 | $72.6M | -9.8% |
| Q4 2024 | $74M | -7.6% |
AMSF's revenue has picked up after four years of holding roughly level: $80M last quarter, down 2.6% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 11% | -10 points |
| Q2 2026 | 20% | -1.7 points |
| Q1 2026 | 13% | -2.8 points |
| Q4 2025 | 16% | -7.1 points |
| Q3 2025 | 21% | -1.3 points |
| Q2 2025 | 22% | +3.4 points |
| Q1 2025 | 15% | -10 points |
| Q4 2024 | 23% | -7.2 points |
AMSF has the edge over IREN on profitability, with a higher operating margin.
IREN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $228M | -5.1% |
| Q2 2026 | $137.2M | -27% |
| Q1 2026 | $144.8M | 0% |
| Q4 2025 | $184.7M | +59% |
| Q3 2025 | $240.3M | +355% |
| Q2 2025 | $187.3M | +230% |
| Q1 2025 | $144.8M | +168% |
| Q4 2024 | $116.1M | +176% |
IREN has the edge over AMSF on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -82% | -50 points |
| Q2 2026 | -452% | -461 points |
| Q1 2026 | -161% | -180 points |
| Q4 2025 | -63% | -79 points |
| Q3 2025 | -32% | +57 points |
| Q2 2025 | 9% | +49 points |
| Q1 2025 | 19% | +8 points |
| Q4 2024 | 15% | +21 points |
IREN's operating margin was −82% last quarter, down 50 points from the same quarter a year ago.
AMSF Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $2.8M | -71% |
| Q2 2026 | $1.8M | +$11.3M |
| Q1 2026 | -$2.7M | -$930K |
| Q4 2025 | $10.5M | -3.4% |
| Q3 2025 | $9.8M | +16% |
| Q2 2025 | -$9.5M | -$6.9M |
| Q1 2025 | -$1.8M | -127% |
| Q4 2024 | $10.8M | +174% |
AMSF has the edge over IREN on cash generation, producing positive trailing cash flow while its opponent burns cash.
IREN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.6B | -$1.6B |
| Q2 2026 | $482.2M | +2895% |
| Q1 2026 | -$873.8M | -$523.1M |
| Q4 2025 | -$468M | -$334M |
| Q3 2025 | -$38M | +$349.4M |
| Q2 2025 | $16.1M | +$179M |
| Q1 2025 | -$350.7M | -$128.7M |
| Q4 2024 | -$134M | -$105.2M |
IREN's free cash flow was −$2.5B over the past year, against −$507M the year before. Free cash flow isn't a meaningful measure for financial services companies like IREN.
AMSF Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.3% | -62.3K shares |
| 1 year | -2.3% | -432K shares |
| 3 years | -3% | -584K shares |
| 5 years | -4% | -768K shares |
| Available history | -3.6% | -689K shares |
AMSF has the edge over IREN on shareholder dilution, with a more favorable share count trend.
IREN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +26% | +82.4M shares |
| 1 year | +10% | +36.9M shares |
| 3 years | +511% | +333M shares |
| 5 years | +624% | +344M shares |
| Available history | +2346% | +382M shares |
IREN has 399M diluted shares, up 10% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
AMSF Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.8x | Net Cash |
| Q2 2026 | -1.1x | Net Cash |
| Q1 2026 | -0.6x | Net Cash |
| Q4 2025 | -1.0x | Net Cash |
| Q3 2025 | -0.9x | Net Cash |
| Q2 2025 | -0.8x | Net Cash |
| Q1 2025 | -0.7x | Net Cash |
| Q4 2024 | -0.6x | Net Cash |
AMSF has more cash than debt. Net leverage isn't a meaningful measure for financial services companies like AMSF.
IREN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | 157.6x | High |
| Q4 2025 | 22.2x | High |
| Q3 2025 | 4.1x | High |
| Q2 2025 | 2.0x | Moderate |
| Q1 2025 | 3.3x | Elevated |
| Q4 2024 | -4.6x | Net Cash |
| Q3 2024 | -16.7x | Net Cash |
| Q2 2024 | -15.9x | Net Cash |
IREN's net debt is more than 20 years of its operating earnings (EBITDA), up from 3.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like IREN.
AMSF Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 24.6 | Oversold |
| Stochastic | 1.7 | Oversold |
AMSF's weekly RSI is 25 (oversold) and its Stochastic is 2 (oversold).
IREN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.3 | Neutral |
| Stochastic | 8.2 | Oversold |
IREN's weekly RSI is 33 (neutral) and its Stochastic is 8 (oversold).
AMSF PE vs Financial Services Sector
| Metric | AMSF | Sector median | Relative |
|---|---|---|---|
| PE | 9x | 13x | 31% below |
| PE % | 0 | 63 | 63 pts below |
AMSF is trading at 9.0x earnings, a 31% discount to the Financial Services sector's median of 13x.
IREN PE vs Financial Services Sector
| Metric | IREN | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
IREN has no meaningful PE right now: it lost money over the past year.
AMSF Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $22.9 | 15% below |
| 20 week MA | $26.5 | 27% below |
| 50 week MA | $31.3 | 38% below |
| 100 week MA | $38.9 | 50% below |
| 200 week MA | $44.7 | 57% below |
AMSF is in a downtrend: it's below all five of its weekly moving averages, and 57% below its 200-week average.
IREN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.8 | 35% below |
| 20 week MA | $36.2 | 46% below |
| 50 week MA | $42.8 | 54% below |
| 100 week MA | $32.0 | 39% below |
| 200 week MA | $19.1 | 2.1% above |
IREN has the edge over AMSF on trend strength, trading above more of its moving averages.
AMSF Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $65.7 | $57.2 | -13% |
| 2021 | $57.2 | $51.6 | -9.8% |
| 2022 | $51.6 | $53.3 | +3.3% |
| 2023 | $53.3 | $46.8 | -12% |
| 2024 | $46.8 | $51.6 | +10% |
| 2025 | $51.6 | $38.5 | -25% |
| 2026 YTD | $38.5 | $19.3 | -50% |
AMSF has the edge over IREN on returns for 2026, with the stronger performance.
IREN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $24.8 | $17.2 | -31% |
| 2022 | $17.2 | $1.19 | -93% |
| 2023 | $1.19 | $7.15 | +501% |
| 2024 | $7.15 | $10.7 | +50% |
| 2025 | $10.7 | $40.3 | +276% |
| 2026 YTD | $40.3 | $19.5 | -52% |
IREN's yearly returns have swung widely, from +501% in 2023 to −93% in 2022. It's down 52% so far in 2026.